[Protective effect of attapulgite against rotavirus infections and toxin LT of Escherichia coli].
Roux
I
I
Czerucka
D
D
Rampal
P
P
D000208:Acute Disease; D001427:Bacterial Toxins / Q000096:biosynthesis*; D002478:Cells, Cultured; D003967:Diarrhea / Q000517:prevention & control* / Q000821:virology; D004768:Enterotoxins / Q000096:biosynthesis*; D004927:Escherichia coli Infections / Q000378:metabolism / Q000517:prevention & control*; D029968:Escherichia coli Proteins; D006801:Humans; D066298:In Vitro Techniques; D017616:Magnesium Compounds / Q000627:therapeutic use*; D012400:Rotavirus Infections / Q000517:prevention & control*; D017655:Silicon Compounds / Q000627:therapeutic use*; D014195:Travel
D001427:Bacterial Toxins; D004768:Enterotoxins; D029968:Escherichia coli Proteins; D017616:Magnesium Compounds; D017655:Silicon Compounds; C027538:heat-labile enterotoxin, E coli; C026325:attapulgite